Загрузка...
Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo
Recently adeno-associated virus (AAV) became the first clinically approved gene therapy product in the western world. To develop AAV for future clinical application in a widespread patient base, particularly in therapies which require intravenous (i.v.) administration of vector, the virus must be ab...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4104587/ https://ncbi.nlm.nih.gov/pubmed/24917028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2014.05.032 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|